Dermata Therapeutics, Inc. Logo

Dermata Therapeutics, Inc.

Medical dermatology company developing and commercializing OTC skin care products.

DRMA | US

Overview

Corporate Details

ISIN(s):
US2498451085
LEI:
Country:
United States of America
Address:
3525 DEL MAR HEIGHTS RD., #322, 92130 SAN DIEGO

Description

Dermata Therapeutics is a medical dermatology company that has shifted its strategic focus to developing and commercializing scientifically-backed over-the-counter (OTC) pharmaceutical products. The company leverages its proprietary Spongilla technology, which combines natural elements with FDA-listed OTC ingredients to create differentiated skin care solutions. Its initial product is a once-weekly acne kit, supported by clinical validation from its Phase 3 START-1 trial. Dermata plans to expand its portfolio with product candidates for other common skin conditions, such as psoriasis and seborrheic dermatitis, aiming to provide patients with accessible and effective treatments to manage their skin health.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Dermata Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Dermata Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Dermata Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Entero Therapeutics, Inc. Logo
Clinical-stage biopharma developing oral therapies for gastrointestinal diseases.
United States of America
ENTO
Entrada Therapeutics, Inc. Logo
Clinical-stage biopharma developing EEV-based therapies for rare diseases.
United States of America
TRDA
Develops small molecule therapeutics for cancer, inflammation, and respiratory diseases.
South Korea
183490
Enzymatica AB Logo
Develops medical devices for infections based on a proprietary marine enzyme technology.
Sweden
ENZY
Epitomee Medical Ltd. Logo
Develops ingestible therapeutic devices for chronic diseases.
Israel
EPIT
EQL Pharma AB Logo
Develops and sells niche generic and specialty medicines, primarily in Nordic markets.
Sweden
EQL
Erasca, Inc. Logo
A clinical-stage oncology company developing therapies for RAS/MAPK pathway-driven cancers.
United States of America
ERAS
Ernexa Therapeutics Inc. Logo
Biopharmaceutical company developing cell therapies for cancer and autoimmune diseases.
United States of America
ERNA
ERYTECH Pharma S.A. Logo
Develops red blood cell-based therapies for cancer and orphan diseases.
France
ERYP
Esperion Therapeutics, Inc. Logo
Develops and commercializes oral medicines to reduce cardiovascular risk.
United States of America
ESPR

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.